Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Bora Pharmaceutical Services Inc | Mississauga, Canada | Makes it, tests it and packages it | Problems found, fixed voluntarilyJan 28, 2025 · 10 inspections |
| Glaxo Operations UK Ltd | Barnard Castle, United Kingdom | Makes it, tests it and packages it | Problems found, fixed voluntarilyFeb 10, 2023 · 8 inspections |
| Patheon Austria GmbH & CoKG | Linz, Austria | Makes the active ingredient and tests it | Problems found, fixed voluntarilySep 12, 2024 · 5 inspections |
| Thermo Fisher Scientific Cork Limited | Carrigaline, Ireland | Makes the active ingredient and tests it | Problems found, fixed voluntarilySep 7, 2022 · 6 inspections, 1 with FDA action |
| Diteba Inc | Mississauga, Canada | Tests it | No problems foundNov 15, 2019 · 2 inspections |
| PPD Development, L.P. | Middleton, WI, United States | Tests it | Problems found, fixed voluntarilySep 25, 2025 · 6 inspections |
Product details
- Generic drug
- Tapinarof: every company that makes it
- Form
- cream, topical
- Strength
- 10 mg per 1 g
- Approval
- NDA NDA215272
- On the market since
- May 28, 2025
- Package NDCs
81672-5051-1- Official label
- DailyMed (National Library of Medicine), updated May 28, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?